| GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
|
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.8243 |
|
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.9623 |
|
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.684 |
|
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.68 |
|
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR7, INSR, KDR, MET, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.3083 |
|
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.09172 |
|
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA1A, AKR1B1, ALOX15, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, POLB, PPARA, SMAD3, SRC, TEK, TYR |
9.09172 |
|
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HSPA1A, HTR2B, PIM1, PPARA, TBXAS1, TYR, XDH |
9.00704 |
|
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.96612 |
|
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
8.87089 |
|
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, HTR5A, IGF1R, INSR, KDR, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TYR |
8.87046 |
|
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.84961 |
|
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F2, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
8.84724 |
|
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SRC, TEK, XDH |
8.49448 |
|
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, HTR5A, IGF1R, INSR, MMP2, MMP9, POLB, PPARA, SRC, TEK, TYR |
8.19453 |
|
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, EGFR, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, SRC, TEK, XDH |
8.15715 |
|
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
8.1504 |
|
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA, TBXAS1 |
7.98673 |
|
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
7.91203 |
|
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
7.90858 |
|
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
7.66381 |
|
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESRRA, F10, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.40081 |
|
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.24875 |
|
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, HTR2A, HTR2B, KDR, SRC, TNKS, TNKS2 |
7.19866 |
|
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, INSR, MET, POLA1, POLB, SMAD3, SRC |
7.03053 |
|
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, POLA1, POLB, PPARA, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
7.03053 |
|
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
6.95663 |
|
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.82186 |
|
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
6.7957 |
|
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, POLB, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
6.74048 |
|
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.66538 |
|
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.66538 |
|
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.55408 |
|
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.48853 |
|
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
6.45558 |
|
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC, TEK |
6.45558 |
|
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, KDR, SRC |
6.40393 |
|
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA3, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
6.40393 |
|
[BP] GO:0042493 |
response to drug
|
ABCB1, ADRA1A, AKR1B1, AXL, CA3, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KDR, POLB, SRC |
6.35627 |
|
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
6.35297 |
|
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTPRS, SIGMAR1, SMAD3, SRC, TEK, TNKS2, TYR |
6.34879 |
|
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.22988 |
|
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F2, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK |
6.18046 |
|
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, ALOX15, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESRRB, F10, F2, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TNKS2, TYR |
6.08298 |
|
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, TNKS, TNKS2 |
6.08006 |
|
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
6.00522 |
|
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, TEK |
5.97031 |
|
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, TBXAS1 |
5.94484 |
|
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
5.84875 |
|
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, F2, FLT3, HSD17B2, HTR5A, INSR, KDR, MMP9, PIM1, POLB, PPARA, PTPRS, SIGMAR1, SMAD3, SRC, TEK, TYR |
5.79135 |
|
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FLT3, HTR5A, SRC, TEK, TYR |
5.67618 |
|
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AXL, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, SIGMAR1, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.66873 |
|
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.60175 |
|
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.60175 |
|
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.60175 |
|
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, GPR35, HTR2A, HTR2B, INSR, MET, SMAD3 |
5.5641 |
|
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.48358 |
|
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, INSR, PPARA, SRC, TEK |
5.47052 |
|
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC, TEK |
5.44102 |
|
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PPARA, TBXAS1 |
5.44102 |
|
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.34495 |
|
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.34104 |
|
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.29519 |
|
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
5.2534 |
|
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A |
5.2316 |
|
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.23134 |
|
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, F2, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.20739 |
|
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.20501 |
|
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPRS, SIGMAR1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
5.18432 |
|
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.1763 |
|
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, F2, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.15876 |
|
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, F2, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, SRC, TEK |
5.09305 |
|
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A |
5.06993 |
|
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SIGMAR1, SMAD3, SRC, TEK, XDH |
5.06461 |
|
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SIGMAR1, SMAD3, SRC, TEK, XDH |
5.01277 |
|
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC, TEK |
5.01277 |
|
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.01277 |
|
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.00602 |
|
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
4.99702 |
|
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
4.99702 |
|
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CHRM2, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, INSR, SIGMAR1, SRC |
4.92679 |
|
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, EGFR, F2, PPARA, SMAD3 |
4.91532 |
|
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
4.90049 |
|
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRA1A, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, XDH |
4.88083 |
|
[BP] GO:0007200 |
None
|
ADRA1A, CHRM2, DRD1, DRD2, ESR1, HTR2A, HTR2B |
4.83596 |
|
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
4.81714 |
|
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, HSD17B1, HSD17B2 |
4.804 |
|
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.80352 |
|
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
4.80174 |
|
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.75069 |
|
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, GPR35, HTR2A, HTR2B, SMAD3 |
4.69232 |
|
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, EGFR, ESRRB, F2, FABP3, FLT3, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
4.67303 |
|
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, EGFR, ESRRB, F2, FABP3, FLT3, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
4.67303 |
|
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.67303 |
|
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, EGFR, HTR2A, HTR2B, KDR, SRC, TEK |
4.61636 |
|
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ALOX15, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
4.60327 |
|
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, F3, FABP4, KDR, MET, PPARA, PTPRS, SMAD3, TEK |
4.6005 |
|
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.57321 |
|
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
4.56253 |
|
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIM1, SIGMAR1, SMAD3, SRC, TEK, XDH |
4.5199 |
|
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.47096 |
|
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KDR, SRC, TEK, XDH |
4.47096 |
|
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, DUSP3, EGFR, HTR2A, HTR2B, KDR, SRC, TEK |
4.43923 |
|
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.40869 |
|
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
4.40711 |
|
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AXL, CA2, CHRM2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F2, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, MMP9, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
4.40164 |
|
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, F2, PPARA, PTPRS, SMAD3, TEK |
4.37853 |
|
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.37259 |
|
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP9, PTPRS, SMAD3, SRC, XDH |
4.37044 |
|
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.37044 |
|
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, SRC, TEK, XDH |
4.36243 |
|
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, AURKB, AXL, CA3, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, PTPRS, SRC, TEK, TNKS, XDH |
4.36243 |
|
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP9, PTPRS, SMAD3, SRC, XDH |
4.36243 |
|
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, HTR5A, SRC, TYR |
4.34731 |
|
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.32475 |
|
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.31761 |
|
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
4.31761 |
|
[BP] GO:0006811 |
None
|
ABCB1, ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
4.29934 |
|
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.29934 |
|
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.26222 |
|
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
4.26001 |
|
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, F2, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, INSR, MMP9, PPARA, SMAD3, SRC |
4.22455 |
|
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK, TNKS, XDH |
4.22455 |
|
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.21977 |
|
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.207 |
|
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.19229 |
|
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F2, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
4.1644 |
|
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A |
4.14073 |
|
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A |
4.14073 |
|
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TEK, TYR |
4.12411 |
|
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
4.12411 |
|
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
4.0973 |
|
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.08368 |
|
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.06435 |
|
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, AURKB, AXL, CA3, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, PTPRS, SRC, TEK, TNKS, XDH |
4.05106 |
|
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, TBXAS1 |
4.01387 |
|
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, EGFR |
4.01118 |
|
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DUSP3, EGFR, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK, XDH |
3.99301 |
|
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
3.93866 |
|
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.93845 |
|
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CA3, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, SRC |
3.92094 |
|
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F2, F3, HCAR2, HSPA1A, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
3.86718 |
|
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.86718 |
|
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, INSR, SMAD3 |
3.81637 |
|
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.80304 |
|
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.76956 |
|
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS |
3.76616 |
|
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.75949 |
|
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.7456 |
|
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.7456 |
|
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS |
3.71753 |
|
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.70125 |
|
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.69811 |
|
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.68827 |
|
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.66913 |
|
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.66207 |
|
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.61099 |
|
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRA1A, AURKB, DRD2, EGFR, ESR1, ESR2, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MET, MMP9, SMAD3, SRC, TEK, TNKS, XDH |
3.59825 |
|
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, HTR2B, INSR, SMAD3, SRC |
3.57946 |
|
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, SRC, TNKS, TNKS2 |
3.56135 |
|
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK |
3.54032 |
|
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.51061 |
|
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.51061 |
|
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, HTR7, PPARA, SRC |
3.48139 |
|
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.47096 |
|
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, DRD2, EGFR, ESRRB, F2, FLT3, HTR2A, HTR2B, INSR, KDR, MMP9, SRC, TEK, XDH |
3.44819 |
|
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
3.4468 |
|
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, F2, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS |
3.41812 |
|
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, SRC, TEK, XDH |
3.40924 |
|
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, POLB, PPARA, SMAD3, SRC, TEK |
3.40924 |
|
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.40112 |
|
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.40112 |
|
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, PPARA, SMAD3, SRC, TNKS, TNKS2 |
3.37629 |
|
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
3.37179 |
|
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.37179 |
|
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.37179 |
|
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.37179 |
|
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.37179 |
|
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.35694 |
|
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.34494 |
|
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.32393 |
|
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, HTR2A |
3.32393 |
|
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, F2, FABP4, HSPA1A, MMP2, PPARA, PTPRS, SMAD3, SRC, TEK |
3.3073 |
|
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.26228 |
|
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.25646 |
|
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.24307 |
|
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.22961 |
|
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.22707 |
|
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, HTR2B, HTR5A, KDR |
3.20265 |
|
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.20213 |
|
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.1684 |
|
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, F2, PPARA, SMAD3, TEK |
3.14102 |
|
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
3.14102 |
|
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
3.12243 |
|
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.12243 |
|
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.12243 |
|
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.12231 |
|
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, F2, PPARA, SMAD3, TEK |
3.08784 |
|
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, KDR, MMP9, SRC, TEK, XDH |
3.08784 |
|
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.08784 |
|
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, CA2, CA7, DRD1, DRD2, DRD3, F2, GPR35, HTR1A, HTR2A, MMP9 |
3.08784 |
|
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.07531 |
|
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
3.07531 |
|
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, INSR, PPARA, SRC |
3.06079 |
|
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, F2, GPR35, HTR2A, HTR2B |
3.05977 |
|
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
3.05775 |
|
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ALOX15, CSNK2A1, DRD2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.05113 |
|
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.04015 |
|
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK, XDH |
3.03458 |
|
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
F2, FLT3, SRC, TEK |
3.03458 |
|
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.03458 |
|
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
3.03053 |
|
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
3.03053 |
|
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM2, DRD2, DRD3, EGFR, GPR35, HCAR2, HTR2A, SMAD3 |
3.01727 |
|
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.01727 |
|
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
3.01174 |
|
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.0047 |
|
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, SRC |
2.95599 |
|
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
2.94603 |
|
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, TBXAS1, TYR |
2.94253 |
|
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, POLB, SRC, TEK |
2.87627 |
|
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.86334 |
|
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
2.86334 |
|
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
2.86334 |
|
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.86334 |
|
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
2.85202 |
|
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.84751 |
|
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
2.84751 |
|
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.83966 |
|
[BP] GO:0040008 |
regulation of growth
|
CSNK2A1, DRD2, DRD3, EGFR, ESR2, F2, HSPA1A, INSR, PIM1, PTPRS, SMAD3, TNKS2 |
2.83392 |
|
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
2.83392 |
|
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.81817 |
|
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.81817 |
|
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.81817 |
|
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, SRC, TEK, TNKS |
2.79294 |
|
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, AURKB, DRD2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, SMAD3, SRC, TEK, TNKS, XDH |
2.76424 |
|
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS |
2.75351 |
|
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, SRC, TEK |
2.75277 |
|
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.73072 |
|
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.73072 |
|
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.73072 |
|
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, POLA1, SMAD3 |
2.73072 |
|
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
2.72518 |
|
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
2.72372 |
|
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.67548 |
|
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
2.67546 |
|
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, GPR35, HTR2A, MMP9 |
2.67355 |
|
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
2.66995 |
|
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, SRC, TEK, TNKS |
2.66489 |
|
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.64953 |
|
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.64699 |
|
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.64699 |
|
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.63427 |
|
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR2B, SRC |
2.62717 |
|
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.58447 |
|
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
2.58287 |
|
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, F2, FABP4, PPARA, SMAD3, TEK |
2.57859 |
|
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.57717 |
|
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.57717 |
|
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57717 |
|
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.57717 |
|
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, FABP3, HSPA1A, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, TNKS, TNKS2, XDH |
2.57717 |
|
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, F2, INSR, SMAD3, XDH |
2.57181 |
|
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, PPARA, SMAD3 |
2.56605 |
|
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, INSR, MET, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.56258 |
|
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.55527 |
|
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, TBXAS1, TYR |
2.55194 |
|
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
2.52232 |
|
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.50683 |
|
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, TBXAS1, TYR |
2.47238 |
|
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46711 |
|
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.46711 |
|
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46711 |
|
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, SRC, TEK |
2.43793 |
|
[BP] GO:0045821 |
None
|
ESRRB, HTR2A, INSR |
2.43793 |
|
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.43793 |
|
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, F2, FLT3, KDR, TEK |
2.43632 |
|
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PPARA |
2.41085 |
|
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
2.40493 |
|
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
2.39983 |
|
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, POLA1, POLB, SMAD3, SRC |
2.383 |
|
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, TEK |
2.383 |
|
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.383 |
|
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, EGFR, F10, F2, FABP3, HSPA1A, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, TNKS, XDH |
2.383 |
|
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.37834 |
|
[BP] GO:0051197 |
None
|
ESRRB, HTR2A, INSR |
2.37834 |
|
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.3688 |
|
[BP] GO:0043550 |
regulation of lipid kinase activity
|
F2, FLT3, SRC, TEK |
2.3688 |
|
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, DRD2, EGFR, F2, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.36327 |
|
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, CA2, CA3, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, F2, HSPA1A, HTR1A, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, SMAD3, SRC, TEK |
2.35127 |
|
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PPARA |
2.34769 |
|
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.34097 |
|
[BP] GO:0044419 |
interspecies interaction between organisms
|
AXL, EGFR, F2, HSPA1A, HTR2A, INSR, KDR, MET, MMP1, POLA1, SMAD3, SRC |
2.33118 |
|
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.33054 |
|
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.32238 |
|
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.31731 |
|
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.31731 |
|
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, F2, INSR, SMAD3, XDH |
2.3091 |
|
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MET, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.29099 |
|
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.29062 |
|
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
2.27401 |
|
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.27281 |
|
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.26963 |
|
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.2685 |
|
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.24979 |
|
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, F2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.24924 |
|
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.2389 |
|
[BP] GO:0006810 |
None
|
ABCB1, ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, F2, FABP3, HSPA1A, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, TNKS, XDH |
2.23185 |
|
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.22987 |
|
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, CA3, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.22987 |
|
[BP] GO:0051098 |
regulation of binding
|
AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
2.22987 |
|
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.22595 |
|
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.22595 |
|
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22595 |
|
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.22595 |
|
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22595 |
|
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, SRC, TEK |
2.22595 |
|
[BP] GO:0051194 |
None
|
ESRRB, HTR2A, INSR |
2.22542 |
|
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.22542 |
|
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.19593 |
|
[BP] GO:0051282 |
None
|
DRD1, DRD2, F2, HTR2A, HTR2B |
2.18019 |
|
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PPARA, SMAD3 |
2.17295 |
|
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.17265 |
|
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.17265 |
|
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17265 |
|
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.16871 |
|
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
2.16871 |
|
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPRS, SMAD3, SRC, XDH |
2.16312 |
|
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, EGFR, HCAR2, HTR2B, MET, PPARA, SMAD3 |
2.16152 |
|
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR2A |
2.16152 |
|
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, SRC |
2.15348 |
|
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.15348 |
|
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.15344 |
|
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.12676 |
|
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.12676 |
|
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, SRC |
2.1215 |
|
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, SMAD3, SRC, TNKS, TNKS2, XDH |
2.10691 |
|
[BP] GO:0050890 |
None
|
ADORA1, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR |
2.08376 |
|
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, KDR, MMP9, SRC, TEK, XDH |
2.08376 |
|
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.08376 |
|
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.08376 |
|
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.08309 |
|
[BP] GO:0050793 |
regulation of developmental process
|
AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F2, F3, HTR2A, INSR, KDR, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
2.0589 |
|
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, TEK |
2.04949 |
|
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.04949 |
|
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.04949 |
|
[BP] GO:0010641 |
None
|
F3, SRC |
2.04949 |
|
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.04949 |
|
[BP] GO:0007598 |
None
|
F10, F3 |
2.04949 |
|
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.04949 |
|
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.04949 |
|
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.04949 |
|
[BP] GO:0045787 |
positive regulation of cell cycle
|
AURKB, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
2.04949 |
|
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
F2, FLT3, KDR, TEK |
2.04949 |
|
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.04949 |
|
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.04949 |
|
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.04949 |
|
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.04949 |
|
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F2, F3, FABP4, KDR, MET, SMAD3 |
2.03871 |
|
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A |
2.03676 |
|
[BP] GO:0006110 |
None
|
ESRRB, HTR2A, INSR, PPARA |
2.0298 |
|
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.0298 |
|
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ALOX15, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.02539 |
|
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.02539 |
|
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.02539 |
|
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.01814 |
|
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.01814 |
|
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.01145 |
|
[BP] GO:0045745 |
None
|
DRD2, DRD3, F2 |
2.01145 |
|
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, CHRM2, DRD1, DRD2, DRD3, F10, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, SIGMAR1, TEK |
7.08767 |
|
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRA1A, ALOX15, AXL, CA2, CA4, CA9, CHRM2, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F2, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, SIGMAR1, SRC, TEK |
6.59315 |
|
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, SIGMAR1, TEK |
5.55441 |
|
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPRS, SMAD3, SRC, TEK |
4.86481 |
|
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPRS, SIGMAR1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR |
4.31761 |
|
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, SIGMAR1, SRC, TBXAS1, TEK, TYR |
3.90147 |
|
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, ADRA1A, CA2, CA4, CA9, CHRM2, DRD1, DRD2, EGFR, HTR2A, INSR, MET, SIGMAR1, SRC, TEK |
3.5036 |
|
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.32238 |
|
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, HTR2A, HTR5A, INSR, KDR, MMP2, MMP9, PIM1, POLA1, PTPRS, SIGMAR1, SMAD3, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.30493 |
|
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.12644 |
|
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AXL, CA12, CA14, CA4, CA9, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, SIGMAR1, TBXAS1, TEK, TYR |
2.08477 |
|
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
18.9293 |
|
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
17.8738 |
|
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, TBXAS1, TNKS, TYR, XDH |
17.0705 |
|
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
11.9459 |
|
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.8903 |
|
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, TEK |
11.334 |
|
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F2, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TNKS, TNKS2, TYR, XDH |
11.1988 |
|
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, F10, F2, F3, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PTPRS, SRC, TBXAS1, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
10.5592 |
|
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, TEK |
10.0392 |
|
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, SMAD3, TEK |
9.75053 |
|
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, TEK |
9.72708 |
|
[MF] GO:0008227 |
None
|
ADRA1A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
8.72273 |
|
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, XDH |
8.53836 |
|
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, EGFR, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SIGMAR1, SRC, TEK |
8.31554 |
|
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.09572 |
|
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
7.93712 |
|
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.88362 |
|
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.72869 |
|
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
7.72869 |
|
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
7.72869 |
|
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, SMAD3, TNKS |
7.20044 |
|
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.03053 |
|
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.02431 |
|
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, TYR |
6.97269 |
|
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.74048 |
|
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.68375 |
|
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.68375 |
|
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.66538 |
|
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.66538 |
|
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.34338 |
|
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F2, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TNKS, TNKS2, TYR, XDH |
6.18208 |
|
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, TBXAS1 |
6.00522 |
|
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, TBXAS1 |
5.74486 |
|
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
5.65969 |
|
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, TYR |
5.36486 |
|
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.15935 |
|
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.88098 |
|
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.83596 |
|
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, POLA1, SRC, TBXAS1, XDH |
4.7145 |
|
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.36243 |
|
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM2, DRD1, DRD2, DRD3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.08656 |
|
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.66913 |
|
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.66913 |
|
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.44819 |
|
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.32393 |
|
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, HSD17B1, PPARA |
3.31971 |
|
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.25646 |
|
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, SMAD3, SRC |
2.90483 |
|
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.90483 |
|
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.86334 |
|
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.86334 |
|
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.81817 |
|
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, SRC, TEK |
2.81144 |
|
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, CBR1, HSD17B1, HSD17B2, XDH |
2.74638 |
|
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.73648 |
|
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP9, PPARA, SMAD3, SRC |
2.695 |
|
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.66995 |
|
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
2.64953 |
|
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, AURKB, AXL, CSNK2A1, EGFR, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SRC, TEK, TUBB3, XDH |
2.56916 |
|
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TUBB3, XDH |
2.56521 |
|
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.40234 |
|
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.32238 |
|
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.2528 |
|
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22595 |
|
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, TUBB3, XDH |
2.08376 |
|
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04949 |
|
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.04949 |
|
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F2, F3, MMP1, MMP2, MMP9 |
2.01145 |